vs
亚什兰（ASH）与null（SDHC）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是null的1.5倍（$386.0M vs $260.4M），null净利率更高（1.4% vs -3.1%，领先4.5%），亚什兰同比增速更快（-4.7% vs -9.4%），亚什兰自由现金流更多（$111.0M vs $8.7M），过去两年null的营收复合增速更高（17.3% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
史密斯韦森品牌公司是美国的枪械制造商，总部位于美国田纳西州玛丽维尔，是该领域历史悠久且知名的生产企业，在民用及警用枪械市场拥有较高的认可度。
ASH vs SDHC — 直观对比
营收规模更大
ASH
是对方的1.5倍
$260.4M
营收增速更快
ASH
高出4.7%
-9.4%
净利率更高
SDHC
高出4.5%
-3.1%
自由现金流更多
ASH
多$102.3M
$8.7M
两年增速更快
SDHC
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $260.4M |
| 净利润 | $-12.0M | $3.5M |
| 毛利率 | 27.2% | 19.9% |
| 营业利润率 | -1.6% | 6.5% |
| 净利率 | -3.1% | 1.4% |
| 营收同比 | -4.7% | -9.4% |
| 净利润同比 | 92.7% | -14.3% |
| 每股收益（稀释后） | $-0.26 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHSDHC
| Q4 25 | $386.0M | $260.4M | ||
| Q3 25 | $477.0M | $262.0M | ||
| Q2 25 | $463.0M | $223.9M | ||
| Q1 25 | $479.0M | $224.7M | ||
| Q4 24 | $405.0M | $287.5M | ||
| Q3 24 | $521.0M | $277.8M | ||
| Q2 24 | $544.0M | $220.9M | ||
| Q1 24 | $575.0M | $189.2M |
净利润ASHSDHC
| Q4 25 | $-12.0M | $3.5M | ||
| Q3 25 | $31.0M | $2.1M | ||
| Q2 25 | $-742.0M | $2.4M | ||
| Q1 25 | $31.0M | $2.7M | ||
| Q4 24 | $-165.0M | $4.1M | ||
| Q3 24 | $17.0M | $5.3M | ||
| Q2 24 | $6.0M | $3.6M | ||
| Q1 24 | $120.0M | $3.0M |
毛利率ASHSDHC
| Q4 25 | 27.2% | 19.9% | ||
| Q3 25 | 33.3% | 21.0% | ||
| Q2 25 | 28.5% | 23.2% | ||
| Q1 25 | 30.7% | 23.8% | ||
| Q4 24 | 27.4% | 25.5% | ||
| Q3 24 | 33.2% | 26.5% | ||
| Q2 24 | 34.2% | 26.7% | ||
| Q1 24 | 28.0% | 26.1% |
营业利润率ASHSDHC
| Q4 25 | -1.6% | 6.5% | ||
| Q3 25 | 12.8% | 6.6% | ||
| Q2 25 | -152.9% | 7.7% | ||
| Q1 25 | 10.6% | 8.7% | ||
| Q4 24 | -44.2% | 10.4% | ||
| Q3 24 | 6.1% | 14.2% | ||
| Q2 24 | -11.2% | 11.7% | ||
| Q1 24 | 3.7% | 11.3% |
净利率ASHSDHC
| Q4 25 | -3.1% | 1.4% | ||
| Q3 25 | 6.5% | 0.8% | ||
| Q2 25 | -160.3% | 1.1% | ||
| Q1 25 | 6.5% | 1.2% | ||
| Q4 24 | -40.7% | 1.4% | ||
| Q3 24 | 3.3% | 1.9% | ||
| Q2 24 | 1.1% | 1.7% | ||
| Q1 24 | 20.9% | 1.6% |
每股收益（稀释后）ASHSDHC
| Q4 25 | $-0.26 | $0.39 | ||
| Q3 25 | $0.83 | $0.24 | ||
| Q2 25 | $-16.21 | $0.26 | ||
| Q1 25 | $0.65 | $0.30 | ||
| Q4 24 | $-3.50 | $0.50 | ||
| Q3 24 | $0.34 | $0.58 | ||
| Q2 24 | $0.12 | $0.40 | ||
| Q1 24 | $2.39 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $12.7M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $86.7M |
| 总资产 | $4.5B | $557.6M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHSDHC
| Q4 25 | $304.0M | $12.7M | ||
| Q3 25 | $215.0M | $14.8M | ||
| Q2 25 | $207.0M | $16.8M | ||
| Q1 25 | $168.0M | $12.7M | ||
| Q4 24 | $219.0M | $22.4M | ||
| Q3 24 | $300.0M | $23.7M | ||
| Q2 24 | $399.0M | $17.3M | ||
| Q1 24 | $439.0M | $32.8M |
总债务ASHSDHC
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
股东权益ASHSDHC
| Q4 25 | $1.9B | $86.7M | ||
| Q3 25 | $1.9B | $82.2M | ||
| Q2 25 | $1.9B | $80.0M | ||
| Q1 25 | $2.6B | $76.9M | ||
| Q4 24 | $2.6B | $73.6M | ||
| Q3 24 | $2.9B | $68.4M | ||
| Q2 24 | $3.0B | $62.1M | ||
| Q1 24 | $3.1B | $59.7M |
总资产ASHSDHC
| Q4 25 | $4.5B | $557.6M | ||
| Q3 25 | $4.6B | $571.6M | ||
| Q2 25 | $4.6B | $570.2M | ||
| Q1 25 | $5.2B | $513.9M | ||
| Q4 24 | $5.2B | $475.9M | ||
| Q3 24 | $5.6B | $460.1M | ||
| Q2 24 | $5.7B | $429.3M | ||
| Q1 24 | $5.9B | $401.3M |
负债/权益比ASHSDHC
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $9.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $8.7M |
| 自由现金流率自由现金流/营收 | 28.8% | 3.4% |
| 资本支出强度资本支出/营收 | 3.6% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 2.77× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $-36.9M |
8季度趋势，按日历期对齐
经营现金流ASHSDHC
| Q4 25 | $125.0M | $9.8M | ||
| Q3 25 | $40.0M | $22.8M | ||
| Q2 25 | $115.0M | $-28.9M | ||
| Q1 25 | $9.0M | $-34.9M | ||
| Q4 24 | $-30.0M | $5.5M | ||
| Q3 24 | $80.0M | $22.9M | ||
| Q2 24 | $127.0M | $39.0K | ||
| Q1 24 | $54.0M | $-9.3M |
自由现金流ASHSDHC
| Q4 25 | $111.0M | $8.7M | ||
| Q3 25 | $6.0M | $21.4M | ||
| Q2 25 | $95.0M | $-31.1M | ||
| Q1 25 | $-12.0M | $-35.9M | ||
| Q4 24 | $-53.0M | $4.8M | ||
| Q3 24 | $42.0M | $22.3M | ||
| Q2 24 | $98.0M | $-2.1M | ||
| Q1 24 | $20.0M | $-9.7M |
自由现金流率ASHSDHC
| Q4 25 | 28.8% | 3.4% | ||
| Q3 25 | 1.3% | 8.2% | ||
| Q2 25 | 20.5% | -13.9% | ||
| Q1 25 | -2.5% | -16.0% | ||
| Q4 24 | -13.1% | 1.7% | ||
| Q3 24 | 8.1% | 8.0% | ||
| Q2 24 | 18.0% | -1.0% | ||
| Q1 24 | 3.5% | -5.1% |
资本支出强度ASHSDHC
| Q4 25 | 3.6% | 0.4% | ||
| Q3 25 | 7.1% | 0.5% | ||
| Q2 25 | 4.3% | 0.9% | ||
| Q1 25 | 4.4% | 0.5% | ||
| Q4 24 | 5.7% | 0.2% | ||
| Q3 24 | 7.3% | 0.2% | ||
| Q2 24 | 5.3% | 1.0% | ||
| Q1 24 | 5.9% | 0.2% |
现金转化率ASHSDHC
| Q4 25 | — | 2.77× | ||
| Q3 25 | 1.29× | 10.70× | ||
| Q2 25 | — | -12.24× | ||
| Q1 25 | 0.29× | -13.01× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | 4.71× | 4.28× | ||
| Q2 24 | 21.17× | 0.01× | ||
| Q1 24 | 0.45× | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
